Showing results (981-990 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|June 6, 2008
Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapiesGilbert G Fareau, Adriana Lopez, Charles Stava, et al.
Anti-Cancer Drugs|March 3, 2017
Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN studyGeorgina Wood, Tal Grenader, Stephen Nash, et al.
Anti-Cancer Drugs|March 18, 2021
Enhanced anticancer activity by the combination of vinpocetine and sorafenib via PI3K/AKT/GSK-3β signaling axis in hepatocellular carcinoma cellsZuo-Yan Zhang, Shu-Min Dong, Ye-Han Liu, et al.
Anti-Cancer Drugs|November 8, 2021
Circular RNA circPDSS1 promotes osteosarcoma progression by sponging miR-502-3p and miR-4436aShaolong Tang, Xinhai Tang, Zhengping Jin, et al.
Anti-Cancer Drugs|November 1, 2012
Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosisStefanie Enzenmüller, Patrick Gonzalez, Klaus-Michael Debatin, et al.
Anti-Cancer Drugs|January 21, 2014
Cytotoxicity of lipophilic statins depends on their combined actions on HIF-1α expression and redox status in B16.F10 melanoma cellsMarius C Alupei, Emilia Licarete, Flavia B Cristian, et al.
Anti-Cancer Drugs|May 23, 2014
A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective studyPhilippe Céruse, Alain Cosmidis, Aurélien Belot, et al.
Anti-Cancer Drugs|May 27, 2014
The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumabMarianne Maillet, Johann Dréanic, Marion Dhooge, et al.
Anti-Cancer Drugs|January 14, 2014
Nature as a remarkable chemist: a personal story of the discovery and development of TaxolMansukh C Wani, Susan Band Horwitz
Anti-Cancer Drugs|May 30, 2014
A systematic review of raltitrexed-based first-line chemotherapy in advanced colorectal cancerSandro Barni, Antonio Ghidini, Andrea Coinu, et al.
Pageof 464